Display options
Cite
Brooks PJ, Francisco GE. Drug therapy of diabetic neuropathy. Clin Podiatr Med Surg. 1992;9(2):257-74
Brooks, P. J., & Francisco, G. E. (1992). Drug therapy of diabetic neuropathy. Clinics in podiatric medicine and surgery, 9(2), 257-74.
Brooks, P J, and Francisco, G E. "Drug therapy of diabetic neuropathy." Clinics in podiatric medicine and surgery vol. 9,2 (1992): 257-74.
Brooks PJ, Francisco GE. Drug therapy of diabetic neuropathy. Clin Podiatr Med Surg. 1992 Apr;9(2):257-74. PMID: 1586903.
Copy Download .nbib Format: NLM
Share it on

Clin Podiatr Med Surg. 1992 Apr;9(2):257-74.

Drug therapy of diabetic neuropathy.

Clinics in podiatric medicine and surgery

P J Brooks, G E Francisco

Affiliations

  1. American Society of Hospital Pharmacists, Bethesda, Maryland.

PMID: 1586903

Abstract

Neuropathy is the most common and perhaps the most devastating complication associated with diabetes. Although many theories regarding the pathogenesis of diabetic neuropathies have been proposed, the most popular theory focuses on the accumulation of sorbitol in the nerve cell through the "polyol pathway." Treatment for diabetic neuropathy remains inadequate. Newer agents such as the aldose reductase inhibitors show some promise in halting and perhaps reversing the pathogenesis of this complication; however, these agents remain investigational. Currently, the most reasonable approach involves the use of agents to control pain and other symptoms associated with this progressive disease.

Similar articles

Substances

MeSH terms

Publication Types

LinkOut - more resources